These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15893618

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F.
    J Infect Dis; 2012 Jul 15; 206(2):212-9. PubMed ID: 22551814
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pathogenesis of West Nile virus infection in dogs treated with glucocorticoids.
    Bowen RA, Rouge MM, Siger L, Minke JM, Nordgren R, Karaca K, Johnson J.
    Am J Trop Med Hyg; 2006 Apr 15; 74(4):670-3. PubMed ID: 16607003
    [Abstract] [Full Text] [Related]

  • 25. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
    Bowen RA, Bosco-Lauth A, Syvrud K, Thomas A, Meinert TR, Ludlow DR, Cook C, Salt J, Ons E.
    Vaccine; 2014 Sep 22; 32(42):5455-9. PubMed ID: 25131745
    [Abstract] [Full Text] [Related]

  • 26. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI, Lieberman MM, Hofmeister E, Nerurkar VR, Wong T, Weeks-Levy C.
    Vaccine; 2008 Oct 03; 26(42):5338-44. PubMed ID: 18723064
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Kurata T, Sata T, Kojima A.
    Vaccine; 2010 Sep 14; 28(40):6588-96. PubMed ID: 20678586
    [Abstract] [Full Text] [Related]

  • 31. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ, Tian ZJ, Tong GZ, Zhou YJ, Ni JQ, Luo YZ, Cai XH.
    Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):309-19. PubMed ID: 15963827
    [Abstract] [Full Text] [Related]

  • 32. A recombinant envelope protein vaccine against West Nile virus.
    Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.
    Vaccine; 2005 Jun 10; 23(30):3915-24. PubMed ID: 15917113
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE, Karlsson KH, Reimer JM, Corbach-Söhle S, Patel S, Richner JM, Nowotny N, Barzon L, Bengtsson KL, Ulbert S, Diamond MS, Stertman L.
    Vaccine; 2014 Feb 07; 32(7):800-8. PubMed ID: 24380682
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J.
    Expert Rev Vaccines; 2007 Apr 07; 6(2):183-91. PubMed ID: 17408368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.